(Q42275198)

19 October 2017

Evaluation of di-sansalvamide A derivatives: synthesis, structure-activity relationship, and mechanism of action (English)

1 reference

19 October 2017

Leslie D Alexander

1

1 reference

19 October 2017

Robert P Sellers

2

1 reference

19 October 2017

Melinda R Davis

3

1 reference

19 October 2017

Veronica C Ardi

4

1 reference

19 October 2017

Victoria A Johnson

5

1 reference

19 October 2017

Robert C Vasko

6

1 reference

19 October 2017

Shelli R McAlpine

7

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

Journal of Medicinal Chemistry

19 October 2017

1 reference

19 October 2017

52

1 reference

19 October 2017

24

1 reference

19 October 2017

7927-7930

1 reference

17 AAG for HSP90 inhibition in cancer--from bench to bedside

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805559

Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock protein 90.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805559

Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805559

A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805559

Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805559

Dimeric approaches to anti-cancer chemotherapeutics

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805559

The heat shock protein 90 chaperone complex: an evolving therapeutic target.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805559

Conformationally based design of macrocycles as antitumor agents

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805559

HSP90 regulates cell survival via inositol hexakisphosphate kinase-2.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805559

The platelet-derived growth factor receptor alpha is destabilized by geldanamycins in cancer cells.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805559

Hsp90 inhibitors as novel cancer chemotherapeutic agents

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805559

Mechanism of Dimer Formation of the 90‐kDa Heat‐Shock Protein

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805559

Liver transplantation with use of cyclosporin a and prednisone

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805559

Effect of dimerization of a beta-turn antimicrobial peptide, PST13-RK, on antimicrobial activity and mammalian cell toxicity

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805559

Reports of clinical benefit of plitidepsin (Aplidine), a new marine-derived anticancer agent, in patients with advanced medullary thyroid carcinoma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805559

The Conformation ofcyclo(−d-Pro−Ala4−) as a Model for Cyclic Pentapeptides of thedL4Type

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805559

Synthesis and cytotoxicity of a new class of potent decapeptide macrocycles

1 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20014866

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1021/JM901566C

1 reference

19 October 2017

1 reference

19 October 2017

PubMed publication ID

20014866

1 reference